Success Metrics

Clinical Success Rate
87.5%

Based on 7 completed trials

Completion Rate
88%(7/8)
Active Trials
2(18%)
Results Posted
14%(1 trials)
Terminated
1(9%)

Phase Distribution

Ph not_applicable
8
73%
Ph phase_1
2
18%
Ph phase_2
1
9%

Phase Distribution

2

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution11 total trials
Phase 1Safety & dosage
2(18.2%)
Phase 2Efficacy & side effects
1(9.1%)
N/ANon-phased studies
8(72.7%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

77.8%

7 of 9 finished

Non-Completion Rate

22.2%

2 ended early

Currently Active

2

trials recruiting

Total Trials

11

all time

Status Distribution
Active(2)
Completed(7)
Terminated(2)

Detailed Status

Completed7
Terminated1
Withdrawn1
Active, not recruiting1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
2
Success Rate
87.5%
Most Advanced
Phase 2

Trials by Phase

Phase 12 (18.2%)
Phase 21 (9.1%)
N/A8 (72.7%)

Trials by Status

terminated19%
withdrawn19%
active_not_recruiting19%
completed764%
recruiting19%

Recent Activity

Clinical Trials (11)

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
11